212 related articles for article (PubMed ID: 2169851)
21. DA-125, a new antitumor agent, inhibits topoisomerase II as topoisomerase poison and DNA intercalator simultaneously.
Seo J; Lee HS; Lee M; Kim M; Shin CG
Arch Pharm Res; 2004 Jan; 27(1):77-82. PubMed ID: 14969343
[TBL] [Abstract][Full Text] [Related]
22. Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors.
Lamond JP; Wang M; Kinsella TJ; Boothman DA
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):369-76. PubMed ID: 8892462
[TBL] [Abstract][Full Text] [Related]
23. DNA topoisomerase inhibitors as antifungal agents.
Shen LL; Fostel JM
Adv Pharmacol; 1994; 29B():227-44. PubMed ID: 8996610
[No Abstract] [Full Text] [Related]
24. Action of etoposide (VP-16-123) on human cells: no evidence for topoisomerase II involvement in excision repair of u.v.-induced DNA damage, nor for mitochondrial hypersensitivity in ataxia telangiectasia.
Downes CS; Mullinger AM; Johnson RT
Carcinogenesis; 1987 Nov; 8(11):1613-8. PubMed ID: 2822276
[TBL] [Abstract][Full Text] [Related]
25. DNA topoisomerases and radiation responses.
Smith PJ
Int J Radiat Biol; 1990 Oct; 58(4):553-9. PubMed ID: 1976716
[No Abstract] [Full Text] [Related]
26. DNA repair functions that control sensitivity to topoisomerase-targeting drugs.
Malik M; Nitiss JL
Eukaryot Cell; 2004 Feb; 3(1):82-90. PubMed ID: 14871939
[TBL] [Abstract][Full Text] [Related]
27. Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells.
Katz EJ; Vick JS; Kling KM; Andrews PA; Howell SB
Eur J Cancer; 1990; 26(6):724-7. PubMed ID: 2168194
[TBL] [Abstract][Full Text] [Related]
28. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
[TBL] [Abstract][Full Text] [Related]
29. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
Lelièvre S; Benchokroun Y; Larsen AK
Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278
[TBL] [Abstract][Full Text] [Related]
30. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
D'Arpa P; Beardmore C; Liu LF
Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
[TBL] [Abstract][Full Text] [Related]
31. Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerase inhibitors in the radiosensitive Chinese hamster irs mutants: phenotypic similarities to ataxia telangiectasia and Fanconi's anaemia cells.
Jones NJ; Ellard S; Waters R; Parry EM
Carcinogenesis; 1993 Dec; 14(12):2487-94. PubMed ID: 8269616
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells exhibit resistance to topoisomerase inhibition.
Nicolay NH; Rühle A; Perez RL; Trinh T; Sisombath S; Weber KJ; Schmezer P; Ho AD; Debus J; Saffrich R; Huber PE
Cancer Lett; 2016 Apr; 374(1):75-84. PubMed ID: 26876302
[TBL] [Abstract][Full Text] [Related]
33. Effect of topoisomerase poisoning by antitumor drugs VM 26, fostriecin and camptothecin on DNA repair replication by mammalian cell extracts.
Frosina G; Rossi O
Carcinogenesis; 1992 Aug; 13(8):1371-7. PubMed ID: 1323426
[TBL] [Abstract][Full Text] [Related]
34. Ku86 modulates DNA topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells.
Shih SJ; Erbele T; Chen AY
Cancer Res; 2005 Oct; 65(20):9194-9. PubMed ID: 16230379
[TBL] [Abstract][Full Text] [Related]
35. DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases.
Hickson ID; Davies SL; Davies SM; Robson CN
Int J Radiat Biol; 1990 Oct; 58(4):561-8. PubMed ID: 1976717
[TBL] [Abstract][Full Text] [Related]
36. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II.
Caldecott K; Banks G; Jeggo P
Cancer Res; 1990 Sep; 50(18):5778-83. PubMed ID: 2168280
[TBL] [Abstract][Full Text] [Related]
37. Topoisomerases in human leukemia.
Peereboom D; Charron M; Kaufmann SH
Adv Pharmacol; 1994; 29B():33-50. PubMed ID: 8996600
[No Abstract] [Full Text] [Related]
38. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
39. 2070-DTI, a topoisomerase inhibitor produced by Streptomyces sp. strain No. 2070.
Suzuki K; Doi S; Yahara S; Uyeda M
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):497-503. PubMed ID: 15008514
[TBL] [Abstract][Full Text] [Related]
40. Suramin inhibits DNA damage in human prostate cancer cells treated with topoisomerase inhibitors in vitro.
Yamazaki H; Dilworth A; Myers CE; Sinha BK
Prostate; 1993; 23(1):25-36. PubMed ID: 8393191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
